Silence Therapeutics (SLN) Restructuring Costs (2025)
Silence Therapeutics (SLN) reported Restructuring Costs of $1.3 million for Q2 2025.
Silence Therapeutics (SLN) Restructuring Costs (2025) Analysis & Trends
Silence Therapeutics (SLN) has 1 years of Restructuring Costs data on file, last reported at $1.3 million in Q2 2025.
- For the quarter ending Q2 2025, Restructuring Costs changed N/A year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2025 stood at $1.3 million (changed N/A YoY), and the FY2025 full-year result was $1.3 million, changed N/A from the prior year.
- Restructuring Costs steadied at $1.3 million in Q2 2025.
- In the past five years, Restructuring Costs ranged from a high of $1.3 million in Q2 2025 to a low of $1.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Silence Therapeutics | 1.59 Bn | 1.45 Bn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.30 Mn |